Sevda Şener Cömert

Sevda Şener Cömert

Auto-generated profile, based on publicly available information

Sevda Şener Cömert

Department of Pulmonary Diseases, University of Health Sciences, Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in Biomolecules and Biomedicine
Verified
Journal Article
Open access
PDF file
BEBerrin Zinnet Eraslan
Berrin Zinnet Eraslan
SCSümeyye Kodalak Cengiz
Sümeyye Kodalak Cengiz
OIOzlem Saniye İçMeli
Ozlem Saniye İçMeli
SSSeda Beyhan Sagmen
Seda Beyhan Sagmen
SCSevda Şener Cömert
Sevda Şener Cömert
The red cell distribution width (RDW)/albumin ratio (RAR) is an inflammation-based prognostic biomarker. To date, its prognostic value in patients with pulmonary thromboembolism (PTE) has been investigated in only one study. This study aimed to assess the effect of RAR on mortality in patients with PTE. Patients admitted for PTE between 2017 and 2023 were retrospectively reviewed. The data collected included demographic information, comorbidities, clinical findings, RDW, albumin, troponin, D-dimer levels, and in-hospital and 30-day mortality outcomes. RAR was calculated by dividing the RDW by albumin. A total of 190 patients were included in the study, of whom 83 (43.7%) were male. The mean age was 63 years (range: 23–89), and the mean RAR was 4.48% ± 1.68% /g/dL. A positive correlation was observed between RAR and both age and troponin level, whereas inverse correlations were noted with systolic blood pressure (sBP), diastolic blood pressure (dBP), and oxygen saturation (SpO2). Using a cutoff value of 5.294 determined by ROC analysis, patients with RAR ≥ 5.294 had a significantly shorter mean survival time than those with RAR value < 5.294 (16.310 months vs 35.163 months; log-rank test, P < 0.001). Multivariate Cox regression analysis identified malignancy (hazard ratio [HR], 4.213; 95% confidence interval [CI], 1.103–16.090; P = 0.035) and RAR (HR: 1.295, 95% CI: 1.035–1.621, P = 0.024) as independent predictors of survival. In conclusion, an RAR value ≥ 5.294 was associated with significantly shorter survival, underscoring its potential utility as a prognostic marker in clinical practice for non-massive PTE.

30 September 2020 in Pulmonology
Verified
Journal Article
Open access
CDCoşkun Doğan
Coşkun Doğan
AFA. Fidan
A. Fidan
SCS.ş. Cömert
S.ş. Cömert
NKN. Kıral
N. Kıral
BSB. Salepçi
B. Salepçi
BCBenan Caglayan
Benan Caglayan
To examine any correlations between tumor maximum standard uptake values (SUVmax) in positron emission tomography-computed tomography (PET-CT) and homogeneous/heterogeneous tumor FDG uptake in PET-CT, and the diagnostic success of the procedure in thoracic ultrasonography (US)-guided transthoracic fine needle aspiration biopsy (TFNAB). The files of patients who underwent thoracic US-guided TFNAB between 2013 and 2018 were examined. Patients who underwent thoracic US-guided TFNAB and were diagnosed as having primary lung cancer were considered as the US-TFNAB diagnostic group. Patients whose disease was diagnosed as primary lung cancer using a different diagnostic method (e.g. CT-guided biopsies, fiberoptic bronchoscopy) due to a lack of diagnosis despite undergoing thoracic US-guided TFNAB were allocated to the US-TFNAB non-diagnostic group. The clinical and radiologic characteristics and PET-CT parameters of the two groups were compared. A total of 104 patients were included in the study; 79 (76%) patients whose disease was diagnosed using US-guided TFNAB, and 25 (24%) patients whose primary lung cancer could not be diagnosed with US-guided TFNAB. The mean SUVmax value of the US-TFNAB diagnostic group was 19.5 ± 10.1, whereas it was 15.1 ± 8.9 in the US-TFNAB non-diagnostic group (p = 0.016). Whether a lesion showed homogeneous or heterogeneous FDG uptake did not effect diagnostic success (p = 0.289). SUVmax value was the only effective independent factor in the diagnostic success of the procedure (p = 0.035). High SUVmax values in PET-CT in lung cancers may increase the diagnostic success of US guided-TFNAB procedures.

1 August 2018 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
BTBurak Tanyıldız
Burak Tanyıldız
GDGizem Doğan
Gizem Doğan
NKNilüfer Zorlutuna Kaymak
Nilüfer Zorlutuna Kaymak
MTMehmet Engin Tezcan
Mehmet Engin Tezcan
AKAhmet Kasım Kılıç
Ahmet Kasım Kılıç
AAAysu Karatay Arsan
Aysu Karatay Arsan
In this study, we present a case of bilateral optic neuropathy and macular ischemia in the right eye associated with neurosarcoidosis. A 26-year-old woman presented to our clinic with complaints of bilateral blurred vision. Bilateral granulomatous anterior uveitis, vitritis, optic neuropathy, and macular ischemia were detected in the right eye in slit-lamp examination. She also reported complaints of fever, weakness, sweating, arthralgia, and headache for 2 months. She was referred to the pulmonary diseases unit of our hospital due to hilar lymphadenopathy seen in her chest x-ray, and biopsies were taken for diagnostic purposes. Histological analysis of the mediastinal lymph node biopsies revealed chronic, non-caseating, granulomatous inflammation. Furthermore, the patient was referred to a neurologist due to concomitant complaint of intense headaches. She was diagnosed with neurosarcoidosis supported by findings on cranial magnetic resonance imaging and lumbar puncture. She received a 3-day course of high-dose (1 g/day) intravenous steroid treatment (methylprednisolone) followed by a tapering dose of oral prednisone. The patient began receiving oral methotrexate 15 mg/ week as a steroid-sparing agent. Significant improvement in neurological and ophthalmological symptoms occurred in the first week of treatment. In this case report, we emphasized that neurosarcoidosis should be included in the differential diagnosis of patients with both bilateral optic neuropathy and macular ischemia. Furthermore, early diagnosis and timely treatment of neurosarcoidosis are important for favorable visual outcomes.

13 February 2026 in Medicine
Verified
Journal Article
Open access
HEHasibe Çiğdem Erten
Hasibe Çiğdem Erten
SCSevda Şener Cömert
Sevda Şener Cömert
TDTalha Doğruyol
Talha Doğruyol
AFAli Fidan
Ali Fidan
GGGonca Gül Geçmen
Gonca Gül Geçmen
RDRecep Demirhan
Recep Demirhan
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease, and lung cancer is a significant comorbidity with high prevalence and adverse impact on survival. Early detection of IPF and targeted interventions require understanding the associated risk factors and clinical presentation of lung cancer in IPF. This single-center, retrospective cohort study aimed to identify risk factors for lung cancer in IPF patients, investigate its clinical features, and determine its impact on survival. Of the 1481 patients with interstitial lung disease, 436 met the criteria for IPF per American Thoracic Society/European Respiratory Society guidelines. Patients followed up for <6 months (n = 31), patients with both IPF and lung cancer (n = 19), and patients whose data were incomplete (n = 18) were excluded from the study. In the end, the study group consisted of 59 patients who developed lung cancer during follow-up, and the control group consisted of 59 randomly selected IPF patients without cancer. Patients’ clinical, radiological, and laboratory data were collected from their medical records. The mean age of the sample, 83.9% of which was male, was 66.9 ± 8.3 years. Emphysema, low body mass index, absence of antifibrotic therapy, presence of weight loss symptoms, and ≥36 pack-years of smoking were significant risk factors for lung cancer ( P <.05), as also confirmed by multivariate analysis. Squamous cell carcinoma was the most common histological type (45.8%), with lower lobe predominance (59.3%) and peripheral location (78.0%). Most tumors (78.0%) were within or adjacent to fibrotic tissue. The median time from IPF diagnosis to lung cancer development was 2.80 years. The 0 to 3, 3 to 5, and >5-year mortality rates for patients with and without lung cancer were 15.2% to 3.3%, 35.5%- 8.4%, and 42.3% to 15.2%, respectively ( P = .026). Our study identified significant risk factors for lung cancer in IPF patients and demonstrated its negative impact on survival. The presence of emphysema, low body mass index, absence of antifibrotic therapy, and ≥36 pack-years of smoking were significantly associated with lung cancer development. Awareness of these factors is crucial for early diagnosis and appropriate treatment strategy determination, potentially improving outcomes in this high-risk population.

23 December 2022 in Family Practice
Verified
Journal Article
Open access
PDF file
MKMeltem Karakulak Kafkas
Meltem Karakulak Kafkas
STSabah Tuzun
Sabah Tuzun
NHNazlı Hacıağaoğlu
Nazlı Hacıağaoğlu
HÇHüseyin Çetin
Hüseyin Çetin
SCSevda Şener Cömert
Sevda Şener Cömert
EŞEngin Ersin Şimşek
Engin Ersin Şimşek
The effect of COVID-19 infection on pulmonary function is unknown. This study aimed to evaluate pulmonary function tests (PFTs) of patients hospitalized with the diagnosis of COVID-19 pneumonia at 3 and 6 months post-discharge. Patients aged 18 years and over who had positive COVID-19 PCR test results and were hospitalized in the pandemic service between 1 May 2020 and 31 October 2020, were included in the study. All patients were evaluated with PFTs FVC, FEV1, FEV1/FVC, and FEF25–75 at 3 and 6 months after discharge. The mean age of 34 patients included in the study was 47.7 ± 12.7 years. The FVC, FEV1, FEV1/FVC, and FEF25–75 measurements at 3 and 6 months post-discharge showed no significant difference (P = 0.765, P = 0.907, P = 0.707, and P = 0.674, respectively). There was no significant difference in any PFT measurements at the third month follow-up, regardless of the pharmacological treatment protocols applied during hospitalization (P > 0.05). However, FEV1/FVC and FEF25–75 levels were 83.1 [3.4]% and 91.0 [10.0]%, respectively, in those who received systemic steroid treatment, and 78.3 ± 8.5% and 72.5 ± 25.7% in those who did not (P = 0.019 and P = 0.048, respectively). In addition, FVC and FEV1 levels increased significantly from the third to the sixth month follow-up in patients who received systemic steroid therapy (P = 0.035 and P = 0.018, respectively). Although there is no significant difference in PFT measurements from 3 to 6 months in COVID-19 patients, systemic steroid therapy may have a beneficial effect on respiratory function in COVID-19 patients.

1 September 2023 in Selcuk Tip Dergisi
Verified
Journal Article
Closed access
SSSelin Gamze Sumen
Selin Gamze Sumen
SCSevda Sener Comert
Sevda Sener Comert
BCBenan Caglayan
Benan Caglayan
Amaç: Bu retrospektif çalışmada, hiperbarik oksijen tedavisinin ardışık uygulamalarda hastaların solunum fonksiyonları ve diyafragma hareketleri üzerindeki etkilerini değerlendirmeyi amaçladık. Hastalar ve Yöntem: Çalışma grubu, Haziran 2019-Aralık 20219 tarihleri arasında hiperbarik oksijen tedavisi uygulanan çeşitli hastalık tanısı alan 22 hastadan oluşuyordu. Dinamik ve statik akciğer hacimleri, difüzyon kapasitesi, maksimum inspiratuar ve ekspiratuar basınçlar gibi solunum fonksiyonları tedavi seanslarının başlamasından ve bitiminden önce değerlendirildi. Ayrıca torasik ultrasonografi ile diyafram kalınlığı, gelgit volümü ve derin inspirasyon sırasındaki diyafram hareketleri ölçüldü. Bulgular: Çalışmaya yaş ortalaması 53.3±10.0 yıl olan yirmi iki hasta (16 erkek;6 kadın) dahil edildi. Hastaların hiperbarik oksijen tedavilerinin sonunda yapılan ölçümlerde total akciğer kapasitesi, vital kapasite ve rezidüel volüm de artış görüldü (p<0.05). Diğer statik akciğer hacimleri, maksimum inspiratuar ve ekspiratuar basınçlar, akciğer karbon monoksit difüzyon kapasitesinde değişiklik gözlenmedi. Tidal volümü hareketi ve vital kapasite sırasında diyafram kalınlığı ve diyafram hareketi artmıştır (p<0.05). Sonuç: Çalışmamızda hiperbarik oksijen tedavisinin diyafram ve solunum fonksiyonları üzerindeki etkisini, spirometri, diyafram görüntüleme teknikleri ve difüzyon kapasitesi yöntemleri ile değerlendirdik. Sonuç olarak, hiperbarik oksijen tedavisi pulmoner ve diyafram kası fonksiyonlarında anlamlı bir değişikliğe yol açmıştır.